Effect of ulinastatin on perioperative organ function and systemic inflammatory reaction during cardiac surgery: A randomized double-blinded study

Korean Journal of Anesthesiology

Volumn 64, Issue 4, 2013, Pages 334-340

  Song, Jieun ^a   Park, Jungmin ^b   Kim, Jee Young ^b   Kim, Joo Duck ^b   Kang, Woon Seok ^b   Muhammad, Hasmizy Bin ^b   Kwon, Mi Young ^c   Kim, Seong Hyop ^b   Yoon, Tae Gyoon ^b   Kim, Tae Yop ^b   Chung, Jin Woo ^b  

^a CHA University   (South Korea)

^b Konkuk University Hospital   (South Korea)

^c National Medical Center   (South Korea)

Author keywords

Cardiopulmonary bypass; Inflammatory; Organ; Ulinastatin

Indexed keywords

CREATINE KINASE MB; CYTOKINE; DOPAMINE; ETOMIDATE; FRESH FROZEN PLASMA; HEPARIN; HETASTARCH; INTERLEUKIN 6; PHENYLEPHRINE; PLACEBO; PROPOFOL; REMIFENTANIL; STEROID; TRANEXAMIC ACID; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

ADULT; AGED; ARTICLE; BISPECTRAL INDEX; BREATHING RATE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART SURGERY; HUMAN; INFLAMMATION; INTRAAORTIC BALLOON PUMP; MEAN ARTERIAL PRESSURE; ORGAN INJURY; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; RECTUM TEMPERATURE; THROMBOCYTE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 84877097923     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2013.64.4.334     Document Type: Article

References (24)

1. Ito H, Hamano K, Gohra H, Katoh T, Fujimura Y, Tsuboi H, et al. Relationship between respiratory distress and cytokine response after cardiopulmonary bypass. Surg Today 1997; 27: 220-225.
2. Picone AL, Lutz CJ, Finck C, Carney D, Gatto LA, Paskanik A, et al. Multiple sequential insults cause post-pump syndrome. Ann Thorac Surg 1999; 67: 978-985.
3. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215-252.
4. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 1993; 40: 1016-1021.
5. Nakahama H, Obata K, Sugita M. Ulinastatin ameliorates acute ischemic renal injury in rats. Ren Fail 1996; 18: 893-898.
6. Ren B, Wu H, Zhu J, Li D, Shen Y, Ying R, et al. Ulinastatin attenuates lung ischemia-reperfusion injury in rats by inhibiting tumor necrosis factor alpha. Transplant Proc 2006; 38: 2777-2779.
7. Cao ZL, Okazaki Y, Naito K, Ueno T, Natsuaki M, Itoh T. Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heart. Ann Thorac Surg 2000; 69: 1121-1126.
8. Hirose J, Ozawa T, Miura T, Isaji M, Nagao Y, Yamashiro K, et al. Human neutrophil elastase degrades inter-alpha-trypsin inhibitor to liberate urinary trypsin inhibitor related proteins. Biol Pharm Bull 1998; 21: 651-656.
9. Endo S, Inada K, Yamashita H, Takakuwa T, Nakae H, Yamada Y, et al. The inhibitory actions of protease inhibitors on the production of polymorphonuclear leukocyte elastase and interleukin 8. Res Commun Chem Pathol Pharmacol 1993; 82: 27-34.
10. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Sekine I. Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury. J Leukoc Biol 2001; 69: 241-247.
11. Nakanishi K, Takeda S, Sakamoto A, Kitamura A. Effects of ulinastatin treatment on the cardiopulmonary bypass-induced hemodynamic instability and pulmonary dysfunction. Crit Care Med 2006; 34: 1351-1357.
12. Hiyama A, Takeda J, Kotake Y, Morisaki H, Fukushima K. A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11: 580-584.
13. Oh SY, Kim JC, Choi YS, Lee WK, Lee YK, Kwak YL. Effects of ulinastatin treatment on myocardial and renal injury in patients undergoing aortic valve replacement with cardiopulmonary bypass. Korean J Anesthesiol 2012; 62: 148-153.
14. Jönsson-Berling BM, Ohlsson K. Distribution and elimination of intravenously injected urinary trypsin inhibitor. Scand J Clin Lab Invest 1991; 51: 549-557.
15. Bingyang J, Jinping L, Mingzheng L, Guyan W, Zhengyi F. Effects of urinary protease inhibitor on inflammatory response during on-pump coronary revascularisation. Effect of ulinastatin on inflammatory response. J Cardiovasc Surg (Torino) 2007; 48: 497- 503.
16. Rady MY, Ryan T, Starr NJ. Early onset of acute pulmonary dysfunction after cardiovascular surgery: risk factors and clinical outcome. Crit Care Med 1997; 25: 1831-1839.
17. Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 1999; 68: 1107-1115.
18. Ng CS, Wan S, Yim AP, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest 2002; 121: 1269-1277.
19. Morse DS, Adams D, Magnani B. Platelet and neutrophil activation during cardiac surgical procedures: impact of cardiopulmonary bypass. Ann Thorac Surg 1998; 65: 691-695.
20. Pallua N, Low JF, von Heimburg D. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of antiinterleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model. Crit Care Med 2003; 31: 1495-1501.
21. Shalaby MR, Waage A, Aarden L, Espevik T. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 1989; 53: 488-498.
22. Beutler B, Cerami A. The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol 1989; 7: 625-655.
23. Andersen LW, Landow L, Baek L, Jansen E, Baker S. Association between gastric mucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 1993; 21: 210-217.
24. Kotani N, Hashimoto H, Sessler DI, Muraoka M, Wang JS, O'Connor MF, et al. Cardiopulmonary bypass produces greater pulmonary than systemic proinflammatory cytokines. Anesth Analg 2000; 90: 1039-1045